Deacylation of A21978C, an acidic lipopeptide antibiotic complex, by Actinoplanes utahensis.
- 31 December 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 41 (8) , 1085-1092
- https://doi.org/10.7164/antibiotics.41.1085
Abstract
A21978C, produced by Streptomyces roseosporus NRRL 11379, is an acidic lipopeptide antibiotic complex that inhibits Gram-positive bacteria. Individual factors of the complex possess an identical peptide core or "nucleus", and are differentiated by the distinctive fatty acid acyl group attached to the N-terminus of the nucleus. Certain members of the family Actinoplanaceae deacylated A21978C to yield the unaltered nucleus, which was then reacylated to form new analogs. Actinoplanes utahensis NRRL 12052 was the most efficient of these cultures, producing up to 500 .mu.g of nucleus per ml of culture broth per hour. Deacylation was also accomplished with semi-pure and tert-butoxycarbonyl (tert-BOC)-A21978C. In the latter, the ornithine amino group was blocked to prevent formation of diacyl analogs during reacylation. The acylase was an endoenzyme present in submerged cultures of A. utahensis from < 18 to > 168 hours of incubation. Whole cells suspended in phosphate buffer or entrapped in polyacrylamide gel also deacylated A21978C efficiently.This publication has 5 references indexed in Scilit:
- Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: The synthesis and evaluation of daptomycin (LY146032).The Journal of Antibiotics, 1988
- Comparative in-vitro activity of LY146032 and eight other antibiotics against Gram-positive bacteria isolated from childrenJournal of Antimicrobial Chemotherapy, 1987
- In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococciJournal of Antimicrobial Chemotherapy, 1987
- A21978C, a complex of new acidic peptide antibiotics. Isolation, chemistry, and mass spectral structure elucidation.The Journal of Antibiotics, 1987
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986